Transfers of Value to Healthcare Professionals
Bayer is committed to fostering transparency in its financial relations with healthcare professionals and believes that it creates trust in the innovative pharmaceutical industry.
Collaborative Research Benefits Patients and Society
The collaboration between the pharmaceutical industry and healthcare professionals has delivered numerous innovative medicines and changed the way many diseases impact our lives. We at Bayer are convinced that close cooperation with and continuous education of healthcare professionals is key to achieving better outcomes for the patients we strive to help.
Pharmaceutical Industry – Healthcare Professionals:
A Highly Regulated Relationship
When collaborating with medical experts, we comply with existing laws and regulations that clearly outline the interaction between industry and healthcare professionals, e.g. healthcare laws and industry codes. Additionally, these rules are amended by different transparency regulations, such as the Sunshine Act in the US, the EFPIA Disclosure Code in Europe, and various local legal reporting obligations. And we fully respect the independence and integrity of these professionals.
Implementing the EFPIA Disclosure Code
As a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and in line with our company values we fully endorse the EFPIA Disclosure Code. In accordance with this Code Bayer will disclose payments as well as benefits in kind to healthcare professionals and healthcare organizations on global and local Bayer websites.
In accordance with the EFPIA Disclosure Code Bayer will disclose payments as well as benefits in kind to healthcare professionals and healthcare organizations by June 2016, at the latest.
Disclosure of Data Reports
Find out how we are collecting and disclosing transfers of value to healthcare professionals and get access to the national data disclosure.